ClearPoint Neuro, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-7.2M | $-8.1M | $-8.4M | $-4.5M | $-7.1M | $-5.9M | $-8.3M | $-9.5M |
| Depreciation & Amortization | $116.5K | $155.7K | $211.9K | $377.3K | $426.2K | $417.0K | $354.9K | $266.2K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.2M | $1.2M | $1.7M | $880.8K | $1.5M | $2.0M | $989.9K | $245.5K |
| Net Cash from Operating Activities | $-6.0M | $-5.8M | $-8.6M | $-7.3M | $-7.8M | $-7.4M | $-6.2M | $-7.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $26.8K | $101.0K | $76.9K | $48.1K | $74.5K | $127.5K | $26.1K | $61.7K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-26.8K | $-101.0K | — | $-48.1K | $-174.5K | $-127.5K | $-26.1K | $-61.7K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $12.0M | $3.8M | — | $13.0M | $9.8M | $9.0M | $4.8M | $6.8M |
| Net Change in Cash | $6.0M | $-2.1M | $-3.8M | $5.7M | $1.9M | $1.5M | $-1.4M | $-991.8K |
| Free Cash Flow | $-6.0M | $-5.9M | $-8.7M | $-7.3M | $-7.9M | $-7.6M | $-6.3M | $-7.8M |